MBS355909 | Anti-SARS-CoV-2 Spike+Nucleocapsid IgG+IgM, Humanized antibody (Positive Control)

Anti-SARS-CoV-2 Spike+Nucleocapsid IgG+IgM, Humanized antibody (Positive Control) | MBS355909 | Mybiosource

Product Short Name: [COVID 19 Spike+Nucleocapsid (NP) IgG+IgM Humanized Coronavirus]

Product Name Synonyme: [2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Nucleocapsid; Nucleoprotein (NP); Spike; IgG; IgM]

Other Names: N/A

Product Gene Name: [COVID-19]

Product Gene Name Synonyme: [2019-nCoV; SARS-CoV-2; SARS coronavirus 2 proteome; COVID19; SARS-CoV2]

Other Gene Names: N/A

Clonality: Monoclonal

Isotype: IgG + IgM

Clone: N/A

Host: Human, humanized antibody cultured in vitro

Reactivity: Viral

Specificity: N/A

Purity: Purity: >95% by HPLC & SDS-PAGE
Purification: Protein A purified

Form: Liquid; 0.01 M PBS without preservative.

Concentration: N/A

Storage Stability: Aliquot and store at -20���C for long term (at least for one year). Avoid repeated freeze and thaw cycles.

Tested Application: Lateral Flow (Rapid Test). Researchers are responsible for verifying the compatibility of this positive control antibody with the antigen/recombinant protein used in their immunoassay.